Proximity to Brainstem at Recurrence is Associated with Decreased Survival in IDH Wild-Type Glioblastoma

被引：0
|
作者：
Bajaj, A. [1 ]
Benishay, E. T. [1 ]
Helenowski, I. B. [2 ]
Savoor, R. [1 ]
Drumm, M. R. [3 ]
Rammohan, N. [4 ]
Sachdev, S. [5 ]
Horbinski, C. M. [6 ]
Kruser, T. [5 ]
机构：
[1] Northwestern Univ, Dept Radiat Oncol, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Prevent Med, Div Biostat, Chicago, IL 60611 USA
[3] Northwestern Univ, Dept Neurol Surg, Chicago, IL 60611 USA
[4] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[5] Northwestern Univ, Dept Radiat Oncol, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA
[6] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3235
引用
收藏
页码：E587 / E587
页数：1
相关论文
共 50 条
  • [41] Performance of a nomogram for IDH-wild-type glioblastoma patient survival in an elderly cohort
    Shen, Erica
    Johnson, Margaret O.
    Lee, Jessica W.
    Lipp, Eric S.
    Randazzo, Dina M.
    Desjardins, Annick
    McLendon, Roger E.
    Friedman, Henry S.
    Ashley, David M.
    Kirkpatrick, John P.
    Peters, Katherine B.
    Walsh, Kyle M.
    NEURO-ONCOLOGY ADVANCES, 2019, 1 (01)
  • [42] GENETIC VARIATION BETWEEN IDH MUTANT AND IDH WILD-TYPE GLIOMA
    Li, Shaoqun
    Lai, Mingyao
    Zhou, Jiangfen
    Zhen, Junjie
    Cai, Linbo
    NEURO-ONCOLOGY, 2021, 23 : 119 - 119
  • [43] A platform for efficient early evaluation of biomarker-associated therapies in newly diagnosed IDH wild-type, MGMT unmethylated glioblastoma
    Colman, Howard
    NEURO-ONCOLOGY, 2019, 21 (01) : 6 - 7
  • [44] Intratumoral heterogeneity of oxygen metabolism and neovascularization uncovers 2 survival-relevant subgroups of IDH1 wild-type glioblastoma
    Stadlbauer, Andreas
    Zimmermann, Max
    Doerfler, Arnd
    Oberndorfer, Stefan
    Buchfelder, Michael
    Coras, Roland
    Kitzwoegerer, Melitta
    Roessler, Karl
    NEURO-ONCOLOGY, 2018, 20 (11) : 1536 - 1546
  • [45] GENOME-WIDE DNA METHYLATION PROFILING AND GENETIC CHARACTERIZATION OF LONG-TERM SURVIVAL IDH WILD-TYPE GLIOBLASTOMA PATIENTS
    Miele, Evelina
    Lazzarini, Elisabetta
    Ciolfi, Andrea
    Pedace, Lucia
    Nardini, Claudia
    Patrizi, Sara
    Mastronuzzi, Angela
    Tartaglia, Marco
    Anghileri, Elena
    Calatozzolo, Chiara
    Lamperti, Elena Antonia
    Patane, Monica
    Locatelli, Franco
    Indraccolo, Stefano
    Pollo, Bianca
    NEURO-ONCOLOGY, 2022, 24 : 115 - 116
  • [46] IDH1 MUTATION SPECIFIC miRNA SIGNATURE PREDICTS FAVORABLE PROGNOSIS IN GLIOBLASTOMA WITH IDH1 WILD-TYPE
    Wang, Zheng
    Bao, Zhaoshi
    Jiang, Tao
    NEURO-ONCOLOGY, 2013, 15 : 91 - 91
  • [47] EXPRESSION ANALYSIS OF IDH1 WILD-TYPE AND MUTANT GLIOMA STEM CELLS UNDER HYPOXIA IDENTIFIES NOVEL SURVIVAL-ASSOCIATED GENES IN GLIOBLASTOMA PATIENTS
    Trong, Philip Dao
    Warta, Rolf
    Geisenberger, Christoph
    Mairbaeurl, Heimo
    Pusch, Stefan
    Unterberg, Andreas
    Herold-Mende, Christel
    NEURO-ONCOLOGY, 2016, 18 : 201 - 201
  • [48] Extracranial metastasis in a IDH- wild type glioblastoma
    Goyal, Richa
    John, Preeti J.
    Bhatoa, Shweta
    Arora, Raman
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2019, 62 (03) : 495 - +
  • [49] Biological underpinnings of radiomic magnetic resonance imaging phenotypes for risk stratification in IDH wild-type glioblastoma
    Fangzhan Guan
    Zilong Wang
    Yuning Qiu
    Yu Guo
    Dongling Pei
    Minkai Wang
    Aoqi Xing
    Zhongyi Liu
    Bin Yu
    Jingliang Cheng
    Xianzhi Liu
    Yuchen Ji
    Dongming Yan
    Jing Yan
    Zhenyu Zhang
    Journal of Translational Medicine, 21
  • [50] Temozolomide for patients with wild-type isocitrate dehydrogenase (IDH) 1 glioblastoma using propensity score matching
    Tunthanathip, Thara
    Sangkhathat, Surasak
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2020, 191
12345